A carregar...
Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid–polymer hybrid nanoparticles
Esophageal cancer is the sixth most common cause of cancer-related death worldwide. Peptide modified nanoparticles have been engineered as novel strategies to improve esophageal adenocarcinoma (EAC) therapy. This study aimed to develop a trastuzumab (TAB) modified system for the delivery of cisplati...
Na minha lista:
| Publicado no: | Drug Deliv |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7598994/ https://ncbi.nlm.nih.gov/pubmed/33118428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2020.1837294 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|